Literature DB >> 11020856

Chemotherapy for gallbladder carcinoma--a surgeon's perspective.

T Todoroki1.   

Abstract

Surgery is the only curative treatment for gallbladder cancer. However, because of frequent local-regional and distant recurrences, radical surgery during advanced stages of the disease is often unsuccessful. Despite potential improvements in patient survival and quality of life, alternatives such as chemotherapeutic regimens have not been fully developed for treatment of gallbladder cancer. The present paper reviews current publications that deal exclusively with the use of chemotherapy for treatment of gallbladder cancer, with particular attention to adjuvant chemotherapy including postoperative and preoperative systemic or regional hepatic arterial infusion chemotherapy. Treatment outcomes, including response rate, adverse effects, and survival are summarized.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11020856

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  8 in total

1.  Evaluation of two modified ECF regimens in the treatment of advanced gallbladder cancer.

Authors:  Jian Dong Wang; Wei Bin Shi; Jun Shen; Peng Yuan Zhuang; Zhi Wei Quan; Xue Feng Wang; Xue Ping Zhou; Song Gang Li; Ying Bin Liu; Yong Yang
Journal:  Med Oncol       Date:  2010-12-07       Impact factor: 3.064

2.  Effect of norcantharidin on proliferation and invasion of human gallbladder carcinoma GBC-SD cells.

Authors:  Yue-Zu Fan; Jin-Ye Fu; Ze-Ming Zhao; Cun-Qiu Chen
Journal:  World J Gastroenterol       Date:  2005-04-28       Impact factor: 5.742

3.  Gallbladder cancer.

Authors:  Sanjeev Misra; Arun Chaturvedi; N C Misra
Journal:  Curr Treat Options Gastroenterol       Date:  2006-04

4.  Combination of calcineurin B subunit (CnB) and 5-fluorouracil reverses 5-fluorouracil-induced immunosuppressive effect and enhances the antitumor activity in hepatocellular carcinoma.

Authors:  Wenlong Zhang; Youxiu Zhong; Hongfei Cui; Liya Wang; Rui Yang; Zhenyi Su; Benqiong Xiang; Qun Wei
Journal:  Oncol Lett       Date:  2017-09-15       Impact factor: 2.967

5.  Outcome of radical surgery for carcinoma of the gallbladder according to the tumor node metastasis and Japanese Society of Biliary Surgery stages.

Authors:  Antonio Frena; Giuseppe La Guardia; Federico Martin
Journal:  J Gastrointest Surg       Date:  2004 Jul-Aug       Impact factor: 3.452

6.  A phase II study of LFP therapy (5-FU (5-fluorourasil) continuous infusion (CVI) and Low-dose consecutive (Cisplatin) CDDP) in advanced biliary tract carcinoma.

Authors:  Kazuma Kobayashi; Akihito Tsuji; Sojiro Morita; Tadashi Horimi; Tetsuhiko Shirasaka; Takashi Kanematsu
Journal:  BMC Cancer       Date:  2006-05-06       Impact factor: 4.430

7.  Guidelines for chemotherapy of biliary tract and ampullary carcinomas.

Authors:  Junji Furuse; Tadahiro Takada; Masaru Miyazaki; Shuichi Miyakawa; Kazuhiro Tsukada; Masato Nagino; Satoshi Kondo; Hiroya Saito; Toshio Tsuyuguchi; Koichi Hirata; Fumio Kimura; Hideyuki Yoshitomi; Satoshi Nozawa; Masahiro Yoshida; Keita Wada; Hodaka Amano; Fumihiko Miura
Journal:  J Hepatobiliary Pancreat Surg       Date:  2008-02-16

8.  The synergistic inhibitory effect of somatostatin-doxorubicin co-treatment on gallbladder carcinoma.

Authors:  Ji-Yu Li; Zhi-Wei Quan; Qiang Zhang; Jian-Wen Liu
Journal:  BMC Cancer       Date:  2007-07-08       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.